July 9, 2025 - 22:15

Caelux has successfully completed its first sale of innovative perovskite glass technology, marking a significant milestone for the company. This cutting-edge product is designed to be paired with a silicon module produced by a well-known manufacturer, enhancing the efficiency and effectiveness of solar energy solutions.
Perovskite materials have gained attention in recent years due to their potential to revolutionize the solar industry, offering higher efficiency rates at a lower production cost compared to traditional solar cells. The combination of Caelux's perovskite glass with established silicon technology could pave the way for more accessible and sustainable solar energy options.
As the demand for renewable energy sources continues to rise, the successful deployment of this technology represents a step forward in the quest for cleaner energy solutions. Industry experts anticipate that this advancement will not only benefit the environment but also contribute to the growth of the solar energy market, making it an exciting development for both investors and consumers alike.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...